Infliximab in ulcerative colitis

Scand J Gastroenterol. 2006 Sep;41(9):997-1000. doi: 10.1080/00365520600857490.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Autoantibodies / drug effects
  • Autoantibodies / immunology*
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / immunology
  • Colitis, Ulcerative / metabolism
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocytes, Helper-Inducer / drug effects
  • T-Lymphocytes, Helper-Inducer / immunology
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / drug effects
  • Tumor Necrosis Factor-alpha / immunology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antibodies, Monoclonal
  • Autoantibodies
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab